摘要
目的:分析高血压伴随冠心病患者采取氨氯地平阿托伐他汀钙片后呈现的药理作用以及整体治疗效果。方法:将2017年11月～2018年11月作为研究时段,从中选取80例确诊为高血压伴随冠心病的患者展开样本研究,对其中40例患者提供硝苯地平控释片(对照组),其余40例患者提供氨氯地平阿托伐他汀钙片参与治疗(研究组),研究两种治疗方法对疾病的改善效果。结果:采取氨氯地平阿托伐他汀钙片参与治疗的研究组患者,经治疗后(SBP、DBP)有明显的下降趋势,血压的控制效果优于对照组;研究组患者治疗后出现不良反应的概率为7.5%,较对照组42.5%低,P<0.05。结论:对患有高血压伴随冠心病患者采取氨氯地平阿托伐他汀钙片治疗后,能够降低患者的血压,减少不良反应的发生。
Objective:To analyze the pharmacological effect and overall therapeutic effect of amlodipine atorvastatin calcium tablet on patients with hypertension and coronary heart disease.Methods:80 patients diagnosed with hypertension and coronary heart disease from November 2017 to November 2018 were selected for the sample study.Among them,40 patients were given nifedipine controlled release tablets (control group),and the remaining 40 patients were given amlodipine atorvastatin calcium tablets (research group),the improvement effect of two treatment methods on the disease were studied.Results:The patients in the study group treated with amlodipine atorvastatin calcium tablet showed a significant downward trend (SBP,DBP) after treatment,and the control effect of blood pressure was better than that of the control group.The incidence of adverse reactions was 7.5% in the study group,lower than 42.5% in the control group,P < 0.05.Conclusion:Amlodipine atorvastatin calcium tablets can reduce the incidence of adverse reactions such as blood pressure reduction in patients with hypertension and coronary heart disease.
作者
肖开
Xiao Kai(Department of Pharmacy,Zhengzhou No.3 People's Hospital,Zhengzhou 450000)
出处
《数理医药学杂志》
2019年第5期745-746,共2页
Journal of Mathematical Medicine
关键词
氨氯地平
阿托伐他汀钙
高血压
冠心病
amlodipine
atorvastatin calcium
high blood pressure
coronary heart disease (CHD)
